Neuropace Inc (NPCE) support and resistance · rev $100.0M
Neuropace Inc (NPCE) is a medical devices company listed on US.
This page maps Neuropace Inc (NPCE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
NPCE currently screens at market cap $312.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NPCE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NPCE quote page for the session range and the stock page for the full model.
Not investment advice.